Opiate Substitution Treatment

"Opiate Substitution Treatment" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Medical treatment for opioid dependence using a substitute opiate such as METHADONE or BUPRENORPHINE.

Descriptor ID	D058850
MeSH Number(s)	E02.319.620
Concept/Terms	Opiate Substitution Treatment Opiate Substitution Treatment Opiate Substitution Treatments Substitution Treatment, Opiate Substitution Treatments, Opiate Treatment, Opiate Substitution Treatments, Opiate Substitution Opioid Substitution Treatment Opioid Substitution Treatments Substitution Treatment, Opioid Substitution Treatments, Opioid Treatment, Opioid Substitution Treatments, Opioid Substitution Opioid Substitution Therapy Opioid Substitution Therapies Substitution Therapies, Opioid Substitution Therapy, Opioid Therapies, Opioid Substitution Therapy, Opioid Substitution Opiate Replacement Therapy Opiate Replacement Therapies Replacement Therapies, Opiate Replacement Therapy, Opiate Therapies, Opiate Replacement Therapy, Opiate Replacement Opioid Replacement Therapy Opioid Replacement Therapies Replacement Therapies, Opioid Replacement Therapy, Opioid Therapies, Opioid Replacement Therapy, Opioid Replacement

Below are MeSH descriptors whose meaning is more general than "Opiate Substitution Treatment".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Therapeutics [E02]
Drug Therapy [E02.319]
Opiate Substitution Treatment [E02.319.620]

Below are MeSH descriptors whose meaning is more specific than "Opiate Substitution Treatment".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Opiate Substitution Treatment" by people in this website by year, and whether "Opiate Substitution Treatment" was a major or minor topic of these publications.

Bar chart showing 87 publications over 13 distinct years, with a maximum of 16 publications in 2022

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2010	1	0	1
2011	2	0	2
2012	5	1	6
2013	2	1	3
2014	5	0	5
2015	6	0	6
2016	3	2	5
2017	5	2	7
2018	6	2	8
2019	4	6	10
2020	4	5	9
2021	1	8	9
2022	0	16	16

Below are the most recent publications written about "Opiate Substitution Treatment" by people in Profiles.

Harrington C, Bailey A, Delorme E, Hano S, Evans EA. "And Then COVID Hits": A Qualitative Study of How Jails Adapted Services to Treat Opioid Use Disorder During COVID-19. Subst Use Misuse. 2023; 58(2):266-274.

View in: PubMed
Randall A, Hull I, Martin SA. Enhancing Patient Choice: Using Self-administered Intranasal Naloxone for Novel Rapid Buprenorphine Initiation. J Addict Med. 2023 Mar-Apr 01; 17(2):237-240.

View in: PubMed
Matsumoto A, Santelices C, Evans EA, Pivovarova E, Stopka TJ, Ferguson WJ, Friedmann PD. Jail-based reentry programming to support continued treatment with medications for opioid use disorder: Qualitative perspectives and experiences among jail staff in Massachusetts. Int J Drug Policy. 2022 11; 109:103823.

View in: PubMed
Jawa R, Walley AY, Wilson DJ, Green TC, McKenzie M, Hoskinson R, Bratberg J, Ramsey S, Rich JD, Friedmann PD. Prescribe to Save Lives: Improving Buprenorphine Prescribing Among HIV Clinicians. J Acquir Immune Defic Syndr. 2022 08 15; 90(5):546-552.

View in: PubMed
Stopka TJ, Rottapel RE, Ferguson WJ, Pivovarova E, Toro-Mejias LD, Friedmann PD, Evans EA. Medication for opioid use disorder treatment continuity post-release from jail: A qualitative study with community-based treatment providers. Int J Drug Policy. 2022 Dec; 110:103803.

View in: PubMed
Fiddian-Green A, Gubrium A, Harrington C, Evans EA. Women-Reported Barriers and Facilitators of Continued Engagement with Medications for Opioid Use Disorder. Int J Environ Res Public Health. 2022 07 30; 19(15).

View in: PubMed
Ober AJ, Murray-Krezan C, Page K, Friedmann PD, Chan Osilla K, Ryzewicz S, Huerta S, Mazer MW, Leamon I, Messineo G, Watkins KE, Nuckols T, Danovitch I. The Substance Use Treatment and Recovery Team (START) study: protocol for a multi-site randomized controlled trial evaluating an intervention to improve initiation of medication and linkage to post-discharge care for hospitalized patients with opioid use disorder. Addict Sci Clin Pract. 2022 07 28; 17(1):39.

View in: PubMed
Glanz JM, Binswanger IA, Clarke CL, Nguyen AP, Ford MA, Ray GT, Xu S, Hechter RC, Yarborough BJH, Roblin DW, Ahmedani B, Boscarino JA, Andrade SE, Rosa CL, Campbell CI. The association between buprenorphine treatment duration and mortality: a multi-site cohort study of people who discontinued treatment. Addiction. 2023 01; 118(1):97-107.

View in: PubMed
Evans EA. Commentary on Adams et al.: using administrative big data for the public good. Addiction. 2022 10; 117(10):2649-2650.

View in: PubMed
Melnick ER, Nath B, Dziura JD, Casey MF, Jeffery MM, Paek H, Soares WE, Hoppe JA, Rajeevan H, Li F, Skains RM, Walter LA, Patel MD, Chari SV, Platts-Mills TF, Hess EP, D'Onofrio G. User centered clinical decision support to implement initiation of buprenorphine for opioid use disorder in the emergency department: EMBED pragmatic cluster randomized controlled trial. BMJ. 2022 06 27; 377:e069271.

View in: PubMed

People

Explore

Similar Concepts

Top Journals